市場調查報告書

血液癌症治療藥的全球市場:2020年

Blood Cancer Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 918130
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
血液癌症治療藥的全球市場:2020年 Blood Cancer Drugs Global Market Report 2020
出版日期: 2019年12月09日內容資訊: 英文
簡介

本報告提供全球血液癌症治療藥市場相關調查分析,市場特徵,市場規模與成長率,市場區隔,各地各國分析,競爭情形,市場佔有率,趨勢,策略等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長

  • 全球血液癌症治療藥市場(成果),2015年∼2019年(10億美元)
    • 市場成長要素
    • 市場阻礙因素
  • 全球血液癌症治療藥市場(預測),2019年∼2022年,2025年,2030年,(10億美元)
    • 市場成長要素
    • 市場阻礙因素

第4章 市場區隔

  • 血液癌症的各類型市場,成果及預測
    • 白血病
    • 淋巴瘤
    • 骨髓瘤
  • 各類醫藥品市場,成果及預測
    • Rituaxan / Mabthera(Rituximab)
    • Gleevac / Glivec(Imatinib)
    • Revlimid(Lenalidomide)
    • Velcade(Bortezomib)
    • Tasigna(Nilotinib)
    • Pomalyst(Pomalidomide)
    • vidaza(Azacitidine)
    • Kyprolis(Carfilzomib)
    • Adcetris(Brentuximab Vedotin)
    • 其他

第5章 血液癌症治療藥市場:地區以及各國分析

  • 各地區市場,成果及預測
  • 各國市場,成果及預測

第6章 亞太地區市場

  • 市場概要
  • 血液癌症的各類型市場,成果及預測
  • 各類醫藥品市場,成果及預測

第7章 中國市場

第8章 印度市場

第9章 日本市場

第10章 澳洲市場

第11章 印尼市場

第12章 韓國市場

第13章 西歐市場

第14章 英國市場

第15章 德國市場

第16章 法國市場

第17章 東歐市場

第18章 俄羅斯市場

第19章 北美市場

第20章 美國市場

第21章 南美市場

第22章 巴西市場

第23章 中東市場

第24章 非洲市場

第25章 市場競爭形勢及企業簡介

  • 市場競爭環境
  • 企業簡介
    • Amgen Inc.
    • AstraZeneca PLC
    • Bayer AG
    • Celgene Corporation
    • Eli Lilly

第26章 市場上主要的收購與合併

第27章 市場趨勢與策略

第28章 產品平台分析

第29章 市場未來展望與潛在力分析

第30章 附錄

  • 簡稱
  • 貨幣
  • 調查相關諮詢方式
  • The Business Research Company
  • 著作權及免責聲明
目錄

Blood Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global blood cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the blood cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Blood Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Blood Cancer Type : Leukemia, Lymphoma, Myeloma 2) By Drugs: Rituaxan/Mabthera (Rituximab), Gleevac/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotinib), Pomalyst (Pomalidomide), Vidaza (Azacitidine), Kyprolis (Carfilzomib), Adcetris (Brentuximab Vedotin), Others

Companies Mentioned: Amgen Inc.,, AstraZeneca PLC,, Bayer AG,, Celgene Corporation,, Eli Lilly,

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Blood Cancer Drugs Market Characteristics

3. Blood Cancer Drugs Market Size And Growth

  • 3.1. Global Blood Cancer Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Blood Cancer Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Blood Cancer Drugs Market Segmentation

  • 4.1. Global Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Leukemia
    • Lymphoma
    • Myeloma
  • 4.2. Global Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Rituaxan/Mabthera (Rituximab)
    • Gleevac/Glivec (Imatinib)
    • Revlimid (Lenalidomide)
    • Velcade (Bortezomib)
    • Tasigna (Nilotinib)
    • Pomalyst (Pomalidomide)
    • Vidaza (Azacitidine)
    • Kyprolis (Carfilzomib)
    • Adcetris (Brentuximab Vedotin)
    • Others

5. Blood Cancer Drugs Market Regional And Country Analysis

  • 5.1. Global Blood Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Blood Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Blood Cancer Drugs Market

  • 6.1. Asia-Pacific Blood Cancer Drugs Market Overview
  • 6.2. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Blood Cancer Drugs Market

  • 7.1. China Blood Cancer Drugs Market Overview
  • 7.2. China Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Blood Cancer Drugs Market

  • 8.1. India Blood Cancer Drugs Market Overview
  • 8.2. India Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Blood Cancer Drugs Market

  • 9.1. Japan Blood Cancer Drugs Market Overview
  • 9.2. Japan Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Blood Cancer Drugs Market

  • 10.1. Australia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Blood Cancer Drugs Market

  • 11.1. Indonesia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Blood Cancer Drugs Market

  • 12.1. South Korea Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Blood Cancer Drugs Market

  • 13.1. Western Europe Blood Cancer Drugs Market Overview
  • 13.2. Western Europe Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Blood Cancer Drugs Market

  • 14.1. UK Blood Cancer Drugs Market Overview
  • 14.2. UK Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Blood Cancer Drugs Market

  • 15.1. Germany Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Blood Cancer Drugs Market

  • 16.4. France Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Blood Cancer Drugs Market

  • 17.1. Eastern Europe Blood Cancer Drugs Market Overview
  • 17.2. Eastern Europe Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Blood Cancer Drugs Market

  • 18.1. Russia Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Blood Cancer Drugs Market

  • 19.1. North America Blood Cancer Drugs Market Overview
  • 19.2. North America Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Blood Cancer Drugs Market

  • 20.1. USA Blood Cancer Drugs Market Overview
  • 20.2. USA Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Blood Cancer Drugs Market

  • 21.1. South America Blood Cancer Drugs Market Overview
  • 21.2. South America Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Blood Cancer Drugs Market

  • 22.1. Brazil Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Blood Cancer Drugs Market

  • 23.1. Middle East Blood Cancer Drugs Market Overview
  • 23.2. Middle East Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Blood Cancer Drugs Market

  • 24.1. Africa Blood Cancer Drugs Market Overview
  • 24.2. Africa Blood Cancer Drugs Market, Segmentation By Blood Cancer Type , Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Blood Cancer Drugs Market, Segmentation By Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Blood Cancer Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Blood Cancer Drugs Market Competitive Landscape
  • 25.2. Blood Cancer Drugs Market Company Profiles
    • 25.2.1. Amgen Inc.
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. AstraZeneca PLC
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Bayer AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Celgene Corporation
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Eli Lilly
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Blood Cancer Drugs Market

27. Blood Cancer Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Blood Cancer Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer